Features of hepatocellular carcinoma in cases with autoimmune hepatitis and primary biliary cirrhosis

World Journal of Gastroenterology

Volumn 15, Issue 2, 2009, Pages 231-239

  Watanabe, Takuya ^a   Soga, Kenji ^a   Hirono, Haruka ^a   Hasegawa, Katsuhiko ^a   Shibasaki, Koichi ^a   Kawal, Hirokazu ^b   Aoyagi, Yutaka ^b  

^a NIPPON DENTAL UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Autoimmune hepatitis; Autoimmune liver disease; Hepatocellular carcinoma; Literature review; Primary biliary cirrhosis

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; IODINATED POPPYSEED OIL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ARTIFICIAL EMBOLISM; AUTOIMMUNE HEPATITIS; BLOOD TRANSFUSION; CANCER MORTALITY; CHEMOEMBOLIZATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; JAPAN; JAPANESE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; RADIOFREQUENCY ABLATION; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; TREATMENT REFUSAL; TUMOR VOLUME;

EID: 59249095361     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.231     Document Type: Article

References (34)

1. Cowling DC, Mackay IR, Taft LI. Lupoid hepatitis. Lancet 1956; 271: 1323-1326
2. Park SZ, Nagorney DM, Czaja AJ. Hepatocellular carcinoma in autoimmune hepatitis. Dig Dis Sci 2000; 45: 1944-1948
3. Floreani A, Niro G, Rosa Rizzotto E, Antoniazzi S, Ferrara F, Carderi I, Baldo V, Premoli A, Olivero F, Morello E, Durazzo M. Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study. Aliment Pharmacol Ther 2006; 24: 1051-1057
4. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 335: 1570-1580
5. Loof L, Adami HO, Sparen P, Danielsson A, Eriksson LS, Hultcrantz R, Lindgren S, Olsson R, Prytz H, Ryden BO. Cancer risk in primary biliary cirrhosis: a population-based study from Sweden. Hepatology 1994; 20: 101-104
6. Turissini SB, Kaplan MM. Hepatocellular carcinoma in primary biliary cirrhosis. Am J Gastroenterol 1997; 92: 676-678
7. Floreani A, Biagini MR, Chiaramonte M, Milani S, Surrenti C, Naccarato R. Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC). Ital J Gastroenterol 1993; 25: 473-476
8. Miyake Y, Iwasaki Y, Terada R, Okamaoto R, Ikeda H, Makino Y, Kobashi H, Takaguchi K, Sakaguchi K, Shiratori Y. Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis. Aliment Pharmacol Ther 2006; 24: 1197-1205
9. Floreani A, Baragiotta A, Leone MG, Baldo V, Naccarato R. Primary biliary cirrhosis and hepatitis C virus infection. Am J Gastroenterol 2003; 98: 2757-2762
10. Maruyama H, Iwamura S, Watanabe S. Three autopsy cases of hepatocellular carcinoma arising from primary biliary cirrhosis (PBC). Okayama Igakkai zasshi 1990; 102: 261-263
11. Shibuya A, Tanaka K, Miyakawa H, Shibata M, Takatori M, Sekiyama K, Hashimoto N, Amaki S, Komatsu T, Morizane T. Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis. Hepatology 2002; 35: 1172-1178
12. Krasner N, Johnson PJ, Portmann B, Watkinson G, Macsween RN, Williams R. Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases. Gut 1979; 20: 255-258
13. Caballeria L, Pares A, Castells A, Gines A, Bru C, Rodes J. Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis. Am J Gastroenterol 2001; 96: 1160-1163
14. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston AL, Fainboim L, Heathcote J, Homberg JC, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RN, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Buschenfelde KH, Zeniya M. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938
15. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, Takayasu K, Nakanuma Y, Makuuchi M, Matsuyama Y, Monden M, Kudo M. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res 2007; 37: 676-691
16. Wang KK, Czaja AJ. Hepatocellular carcinoma in corticosteroid-treated severe autoimmune chronic active hepatitis. Hepatology 1988; 8: 1679-1683
17. Miyake Y, Sakaguchi K, Tanaka H, Nakamura S, Kobayashi Y, Fujioka S, Iwasaki Y, Shiratori Y. Development of hepatocellular carcinoma in a woman with HBV- and HCV-negative autoimmune hepatitis with unsatisfactory response to Corticosteroid. Intern Med 2005; 44: 949-953
18. Shimizu A, Koyama M, Okuda Y, Takase K, Nakano T, Tameda Y. Hepatocellular carcinoma in primary biliary cirrhosis: a case report and review of the Japanese literature. Hepatogastroenterology 1998; 45: 2352-2355
19. Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Craxi A, Farinati F, Missale G, Smedile A, Tiribelli C, Villa E, Raimondo G. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 2004; 126: 102-110
20. Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, Squadrito G, Levrero M, Raimondo G. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 2007; 45: 277-285
21. Ryder SD, Koskinas J, Rizzi PM, McFarlane IG, Portmann BC, Naoumov NV, Williams R. Hepatocellular carcinoma complicating autoimmune hepatitis: role of hepatitis C virus. Hepatology 1995; 22: 718-722
22. Nakai T, Shiroishi O, Kawabe T. Prognosis and positive rate of HBV-DNA in liver tissue of the operative cases of hepatocellular carcinoma with non-B, non-C hepatitis. 40th Annual Meeting of Liver Cancer Study Group of Japan, 2004: 150
23. Kubo S, Oba K, Hirohashi K, Tanaka H, Shuto T, Takemura S, Yamamoto T, Tamori A, Enomoto M, Nishiguchi S. Alcohol abuse as an etiologic factor for hepatocellular carcinoma in Japan. Hepatol Res 2005; 31: 73-78
24. Yamada N, Nomoto M, Ichida T, Aoyagi Y. Primary biliary cirrhosis -diagnosis of condition, therapy, prognosis -2. Malignancy with primary biliary cirrhosis. Tokyo: Chugai igakusha, 2003: 68-75
25. Miura Y, Kaneda Y, Toyama J, Katayama S, Takigawa Y, Nakadate I, Saito Y, Yamazaki K, Hanme T, Yoshida T, Kashiwabara N, Suzuki K, Sato S, Masuda T. Icteric type hepatoma in a patient with primary biliary cirrhosis. Kan Tan Sui 1994; 28: 129-134
26. Nijhawan PK, Therneau TM, Dickson ER, Boynton J, Lindor KD. Incidence of cancer in primary biliary cirrhosis: the Mayo experience. Hepatology 1999; 29: 1396-1398
27. Suzuki A, Lymp J, Donlinger J, Mendes F, Angulo P, Lindor K. Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol 2007; 5: 259-264
28. Watanabe M, Moritani M, Hamamoto S, Uchida Y, Ishihara S, Adachi K, Kinoshita Y. Hepatocellular carcinoma complicating HCV-negative autoimmune hepatitis without corticosteroid therapy. J Clin Gastroenterol 2000; 30: 445-446
29. Ogata S, Maeyama S, Tobe N, Koike J, Uchikoshi T, Takahashi Y, Okuse C, Osada T, Tomoe M, Hayashi T, Suzuki M, Iino S. An autopsy case of hepatocellular carcinoma arising from autoimmune Hepatitis. Kanzo 2000; 41: 48-52
30. Takenawa H, Sakuma I, Yamaoka K, Yamane M, Shaura K, Sakai H, Ikeda T, Marumo F, Sato C. Hepatocellular carcinoma complicating primary biliary cirrhosis - a case report and a review of the literature. Nippon Shokakibyo Gakkai Zasshi 1994; 91: 2127-2132
31. Watanabe H, Danjo N, Shijo H. A case report of viral marker negative hepatocellular carcinoma (HCC) associated with primary biliary cirrhosis (PBC) stage-II. Kanzo 2000; 41: 413-418
32. El-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol 2001; 96: 2462-2467
33. Watanabe T, Aikawa K, Kanefuji T, Yamazaki K, Hirono H, Hasegawa K, Soga K, Shibasaki K, Umezu H, Nomoto M. Pelioid-type hepatocellular carcinoma with numerous eosinophilic infiltrations in a patient with primary biliary cirrhosis. Hepatol Res 2008; 38: 421-427
34. Adachi E, Maeda T, Kajiyama K, Kinukawa N, Matsumata T, Sugimachi K, Tsuneyoshi M. Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer 1996; 77: 2022-2031